Pathogen News and Research

RSS

Link between gut dysbiosis and chronic diseases explored in new study

Study explores the ecological causes of gut dysbiosis and its link to human diseases, revealing how imbalances in gut microbiota composition, influenced by host-derived factors like oxygen and nitrate, contribute to various chronic conditions.

5 Dec 2023

Financial investors hold leverage to mitigate emerging infectious disease risks

Many emerging and re-emerging infectious diseases, especially zoonotic diseases such as ebola or new coronaviruses, emerge as the result of intensified human activities such as deforestation, expansion of agricultural land, and increased hunting and trading of wildlife.

4 Dec 2023

Study links placental Group B Streptococcus to higher neonatal unit admissions in newborns

The clinical significance of Streptococcus agalactiae (Group B Streptococcus; GBS) deoxyribonucleic acid (DNA) in the placenta.

4 Dec 2023

New technique developed to rapidly detect genetic changes in malaria parasites

Scientists have developed a technique to rapidly and reliably detect genetic changes in malaria parasites in Ghana, using just a gaming laptop and portable MinION sequencer from Oxford Nanopore.

4 Dec 2023

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

The first case of a new strain of ‘swine flu’ has been detected in a human in the UK. The last swine flu pandemic killed 457 people in Britain alone. A leading testing expert says this strain looks to be very different but is urging Brits to take precautions.

4 Dec 2023

IU researchers uncover novel mechanism of pathogen entry into cells

Similar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknown process by which pathogens enter a cell with physical force, breaching the body's immune defenses that prevent infection.

1 Dec 2023

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Study reveals that pregnant women infected with COVID-19 had a higher risk of preterm delivery, with significant health and socioeconomic implications. However, early vaccination adopters showed protection from these effects, highlighting the critical role of vaccines in safeguarding future generations' health, especially in the U.S., where the study was conducted.

28 Nov 2023

Machine learning unlocks secrets of antimicrobial resistance, identifying over 900 key genes

Researchers employed advanced techniques like gene annotation, pangenomics, and machine learning to identify over 900 genes responsible for antimicrobial resistance in 12 bacterial species, outperforming traditional identification methods. This breakthrough approach offers new insights into the genetic basis of resistance, potentially guiding the development of more effective antibiotics

27 Nov 2023

Fiber-free diet key to treating childhood Crohn's disease, new study finds

Research reveals how a fiber-free diet in Exclusive Enteral Nutrition (EEN) helps treat Crohn's disease in children by affecting the intestinal pathobiont Mucispirillum schaedleri. It shows that this diet alters gut microbiota, reducing Mucispirillum's pathogenicity and aiding in managing colitis.

26 Nov 2023

Scientists succeed in mapping a central part of the immune system

A new paper in Science Advances details how scientists have succeeded in mapping a central part of the immune system - the HLA class II molecules - while accurately predicting how they display fragments of pathogens on the surface of cells.

24 Nov 2023

New insights into how SARS-CoV-2 evades our immune system

This review in Cellular and Molecular Immunology delves into the innate immune response to SARS-CoV-2, exploring how the virus evades immunity and the potential role of innate immunity in long-COVID and vaccine responses, shedding light on future therapeutic strategies.

23 Nov 2023

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism -; the intrinsic link between metabolism in immune cells and their immune function.

20 Nov 2023

Kiwi cafés sizzle with success on meat-free mondays, cooking up environmental change

Study explores the implementation and support of Meat-Free Mondays in New Zealand's hospital cafés, finding strong participation and environmental concerns as key drivers while identifying knowledge gaps and taste preferences as main barriers to its success.

20 Nov 2023

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

The study reveals a significant presence of enteric pathogens in children from Alabama's Black Belt region, linking well water consumption to increased pathogen detection and underscoring the need for improved sanitation infrastructure.

19 Nov 2023

Unraveling the immune system's response to nanoparticle drug delivery

To reduce the side effects associated with chemotherapy treatments, researchers have investigated the use of delivery systems that can take more drugs directly to the tumor. Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy is one of those researchers.

17 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB.

16 Nov 2023

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

An interview with Dr Beverley Isherwood.

16 Nov 2023

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test-;a phenomenon known as virologic rebound.

13 Nov 2023

Study unravels the molecular mechanisms underlying influenza B virus pathogenicity

Announcing a new article publication for Zoonoses journal. Influenza B virus is a significant respiratory pathogen responsible for seasonal influenza.

13 Nov 2023

Pathogen News and Research

Link between gut dysbiosis and chronic diseases explored in new study

Financial investors hold leverage to mitigate emerging infectious disease risks

Study links placental Group B Streptococcus to higher neonatal unit admissions in newborns

New technique developed to rapidly detect genetic changes in malaria parasites

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

IU researchers uncover novel mechanism of pathogen entry into cells

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Machine learning unlocks secrets of antimicrobial resistance, identifying over 900 key genes

Fiber-free diet key to treating childhood Crohn's disease, new study finds

Scientists succeed in mapping a central part of the immune system

New insights into how SARS-CoV-2 evades our immune system

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

Kiwi cafés sizzle with success on meat-free mondays, cooking up environmental change

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

Unraveling the immune system's response to nanoparticle drug delivery

Promising new cancer therapy appears to be extremely potent against tuberculosis

Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

Study unravels the molecular mechanisms underlying influenza B virus pathogenicity

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News